Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-16

Clinical Trial Update: The Effects of Chicken Extract and a Peptide Supplement for the Prevention of Cognitive Decline in Non-demented Elderly Adults [EARLY_Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluating whether chicken extract and a peptide supplement can help prevent cognitive decline in non-demented elderly adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chicken extract
  • Peptide supplement (peptide supplement)

Snippet

Sponsor: Brand's Suntory Asia | Conditions: Cognitive Decline, Mild Cognitive Impairment | EARLY_Phase 1 | Status: COMPLETED